Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.
PISCATAWAY, N.J. –Camber Pharmaceuticals is excited to announce the addition of bortezomib for injection.
Bortezomib for injection is a proteasome inhibitor indicated for:
• treatment of adult patients with multiple myeloma
• treatment of adult patients with mantle cell lymphoma
Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.
Walgreens SVP and Chief Pharmacy Officer rallies the industry to modernize, collaborate, and advocate with “one voice” for the future of pharmacy care.
Chlorzoxazone tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
2025 State of Drug Access report from RazorMetrics reveals new insights into consumer feelings about pharmacy access.
The updated UL is part of CRN’s ongoing release of revised nutrient safety chapters from its Vitamin and Mineral Safety (4th edition).
Former H-E-B COO and NACDS Chair celebrated for visionary leadership and lasting impact on chain pharmacy industry.
Walgreens SVP and Chief Pharmacy Officer rallies the industry to modernize, collaborate, and advocate with “one voice” for the future of pharmacy care.
Chlorzoxazone tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
2025 State of Drug Access report from RazorMetrics reveals new insights into consumer feelings about pharmacy access.
